Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/9766277E85BA9C4FB7B77FC348EB5C9BD90E8B4310C42AF078012BAA9746D9083299AC7223B2866D14E0F3C4D81AB812http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/9766277E85BA9C4FB7B77FC348EB5C9BD90E8B4310C42AF078012BAA9746D9083299AC7223B2866D14E0F3C4D81AB812http://www.w3.org/2000/01/rdf-schema#comment"C646 treatment attenuated ETV1 protein expression and inactivated KIT-dependent pathways. Taken together the present study suggests that CBP/p300 may serve as novel antineoplastic targets and that use of the selective HAT inhibitor C646 is a promising antitumor strategy for Gastrointestinal stromal tumors."xsd:string
http://purl.uniprot.org/uniprot/#_B17D60C43B6FE183B3088997437EE835CD954673BC3FB57DCA603E783B32AD6E1B6252D221F97063AA16D3270B8F6F3Dhttp://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/9766277E85BA9C4FB7B77FC348EB5C9BD90E8B4310C42AF078012BAA9746D9083299AC7223B2866D14E0F3C4D81AB812
http://purl.uniprot.org/uniprot/B5A224http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/9766277E85BA9C4FB7B77FC348EB5C9BD90E8B4310C42AF078012BAA9746D9083299AC7223B2866D14E0F3C4D81AB812
http://purl.uniprot.org/uniprot/#_B5A224-mappedCitation-27633918http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/9766277E85BA9C4FB7B77FC348EB5C9BD90E8B4310C42AF078012BAA9746D9083299AC7223B2866D14E0F3C4D81AB812